k-tab õhukese polümeerikattega tablett
redson pharmaceuticals - kaaliumkloriid - õhukese polümeerikattega tablett - 600mg 100tk
potassium chloride extended release tablets usp 600 mg toimeainet prolongeeritult vabastav tablett
apex formulations pvt. ltd. - kaaliumkloriid - toimeainet prolongeeritult vabastav tablett - 600mg 100tk
potmax-600 toimeainet prolongeeritult vabastav tablett
supermax drugs & pharmaceuticals pvt. ltd. - kaaliumkloriid - toimeainet prolongeeritult vabastav tablett - 600mg 100tk
kci-retard toimeainet prolongeeritult vabastav tablett
famar l´aigle - kaaliumkloriid - toimeainet prolongeeritult vabastav tablett - 600mg 40tk
kaleorid lp 600mg toimeainet prolongeeritult vabastav tablett
leo pharma a/s - kaaliumkloriid - toimeainet prolongeeritult vabastav tablett - 600mg 30tk
kalinor-retard p toimeainet prolongeeritult vabastav kõvakapsel
itc farma srl - kaaliumkloriid - toimeainet prolongeeritult vabastav kõvakapsel - 600mg 100tk
sando-k kihisev tablett
elara pharmaservices limited - kaaliumkloriid+kaaliumvesinikkarbonaat - kihisev tablett - 600mg+400mg 100tk
low-k õhukese polümeerikattega tablett
redson pharmaceuticals - kaaliumkloriid - õhukese polümeerikattega tablett - 600mg 100tk
rivaroxaban accord
accord healthcare s.l.u. - rivaroksabaan - acute coronary syndrome; coronary artery disease; peripheral arterial disease; venous thromboembolism; stroke; atrial fibrillation; pulmonary embolism - antitrombootilised ained - täiskasvanud patsientidel, kellele tehti plaaniline puusa- või põlveliigese asendamise operatsiooni venoosse trombemboolia (vte) ennetamine. ravi süvaveenide tromboos (dvt) ja kopsuarteri emboolia (pe), ning ennetamine korduvate digi-tv ja pe täiskasvanutel. (see section 4. 4 for haemodynamically unstable pe patients. ravi süvaveenide tromboos (dvt) ja kopsuarteri emboolia (pe), ning ennetamine korduvate digi-tv ja pe täiskasvanutel. (see section 4. 4 haemodynamically ebastabiilne pe patsientidel). adultsprevention of stroke and systemic embolism in adult patients with non valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. ravi süvaveenide tromboos (dvt) ja kopsuarteri emboolia (pe), ning ennetamine korduvate digi-tv ja pe täiskasvanutel. (see section 4. 4 for haemodynamically unstable pe patients. )paediatric populationtreatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. rivaroxaban accord, co administered with acetylsalicylic acid (asa) alone or with asa plus ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers (see sections 4. 3, 4. 4 ja 5. rivaroxaban accord, co administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. adultsprevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. ravi süvaveenide tromboos (dvt) ja kopsuarteri emboolia (pe), ning ennetamine korduvate digi-tv ja pe täiskasvanutel. (see section 4. 4 for haemodynamically unstable pe patients. )paediatric populationtreatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.
carbalex 200 mg tablett
g.l. pharma gmbh - karbamasepiin - tablett - 200mg 50tk